Eton Pharmaceuticals (ETON) Other Non Operating Income (2021 - 2024)

Eton Pharmaceuticals (ETON) has 4 years of Other Non Operating Income data on file, last reported at $1.2 million in Q4 2024.

• For the quarter ending Q4 2024, Other Non Operating Income rose 238.39% year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2024 stood at $1.2 million (up 3809.68% YoY), and the FY2025 full-year result was -$424000.0, down 136.87% from the prior year.
• Other Non Operating Income improved to $1.2 million in Q4 2024, from -$831000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $1.2 million in Q4 2024 to a low of -$831000.0 in Q4 2023.
• A 4-year average of $459200.0 and a median of $800000.0 in 2023 frame the typical range for Other Non Operating Income.
• Across the five-year window, Other Non Operating Income slumped 202.34% in 2023 and jumped 238.39% in 2024, its largest moves.
• Tracing ETON's Other Non Operating Income over 4 years: stood at $365000.0 in 2021, then surged by 122.47% to $812000.0 in 2022, then tumbled by 202.34% to -$831000.0 in 2023, then jumped by 238.39% to $1.2 million in 2024.
• Business Quant data shows ETON's Other Non Operating Income at $1.2 million in Q4 2024, -$831000.0 in Q4 2023, and $800000.0 in Q2 2023.